Does The No. 1 Biotech Stock Have The Next Ketamine On Its Hands?: Top-notch biotech stock Neurocrine surged Tuesday after analysts suggested the company's ...
investors.com/news/technology/biotech-stock-neurocrine-stock-depression-treatment-win/
Neurocrine Biosciences (NBIX) Q4 2023 Earnings Call Transcript: Neurocrine Biosciences Inc. (NASDAQ:NASDAQ:NBIX) Q4 2023 Earnings Conference Call February 7 ...
seekingalpha.com/article/4668265-neurocrine-biosciences-nbix-q4-2023-earnings-call-transcript
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts: The top five biotech stocks today have several commonalities. Among them are Strong ratings ...
investors.com/news/technology/biotech-stocks-the-top-5-to-watch-amid-a-blazing-hot-run/
Neurocrine Biosciences: Fear Not The IRA: Fears of IRA's impact on Neurocrine's Ingrezza are overblown and it is well positioned to grow in the following decade ...
seekingalpha.com/article/4655190-neurocrine-biosciences-fear-not-the-ira
Paid articlePaid
The $660 Million Opportunity Driving This IBD Stock Of The Day Higher: Neurocrine is Tuesday's IBD Stock Of The Day. After unveiling promising results for a ...
investors.com/research/ibd-stock-of-the-day/nbix-stock-the-opportunity-driving-shares-higher/
Voyager to Get as Much as $1.7 Billion in Neurocrine Partnership: Neurocrine Biosciences Inc. entered an agreement with Voyager Therapeutics Inc ...
bloomberg.com/news/articles/2023-01-09/voyager-to-receive-as-much-as-1-7-billion-in-neurocrine-deal
Searching for value in the battered biotech sector, which may not have hit bottom yet
cnbc.com/2022/06/04/searching-for-value-in-the-battered-biotech-sector-which-may-not-have-hit-bottom-yet.html
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics